GlassScriptPhysician profile
Yogesh R Patel
NPI 1235157876
$3,298.07
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $65.67 · 2021: $315 · 2022: $1,897 · 2023: $246 · 2024: $92.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,680.39 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $269.51 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $233.36 | 2019 | |
| Boston Scientific Corporation | $133.80 | 2021-2023 | Watchman Access System |
| Medtronic Vascular, INC. | $127.56 | 2019 | |
| Vifor Pharma, INC. | $107.05 | 2019-2020 | |
| Amgen INC. | $88.49 | 2019-2021 | |
| Chiesi USA, INC. | $86.38 | 2021 | |
| Novartis Pharmaceuticals Corporation | $86.19 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $80.20 | 2019-2023 | Farxiga |
| Braemar Manufacturing, LLC | $58.69 | 2019 | |
| Shockwave Medical, INC | $54.57 | 2022 | |
| Spinal Simplicity, LLC | $45.32 | 2022 | |
| Amarin Pharma, INC. | $36.69 | 2021 | |
| Abbott Laboratories | $30.33 | 2023 | Diamondback Coronary |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.08 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $28.78 | 2019-2022 | |
| Getinge USA Sales, LLC | $24.46 | 2021 | |
| Cardiovascular Systems INC. | $22.55 | 2023 | Diamondback Coronary |
| Edwards Lifesciences Corporation | $21.60 | 2022 | |
| Gilead Sciences, INC. | $14.74 | 2019 | |
| Merck Sharp & Dohme LLC | $13.74 | 2022 | |
| Vistapharm, INC. | $12.49 | 2021 | |
| Pfizer INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yogesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.